Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · IEX Real-Time Price · USD
22.78
-0.36 (-1.56%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $343.65 million as of July 2, 2024. Its market cap has increased by 145.29% in one year.
Market Cap
343.65M
Enterprise Value
227.31M
1-Year Change
145.29%
Ranking
Category
Stock Price
$22.78
Market Cap Chart
Since November 20, 2019, Jasper Therapeutics's market cap has increased from $125.00M to $343.65M, an increase of 174.92%. That is a compound annual growth rate of 24.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 349.10M | 296.70% |
| Dec 29, 2023 | 88.00M | 380.87% |
| Dec 30, 2022 | 18.30M | -93.84% |
| Dec 31, 2021 | 297.10M | 137.49% |
| Dec 31, 2020 | 125.10M | -0.64% |
| Dec 31, 2019 | 125.90M | 0.72% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organogenesis Holdings | 352.64M |
| Scilex Holding Company | 349.70M |
| Anavex Life Sciences | 349.57M |
| Pacific Biosciences of California | 348.62M |
| Kyverna Therapeutics | 347.08M |
| Absci | 335.86M |
| ADC Therapeutics | 334.87M |
| AxoGen | 328.66M |